Impact of introducing multiple evidence-based clinical practice protocols in a medical intensive care unit: A retrospective cohort study

被引：21

作者：

Afessa B. ^{[1
]}

Gajic O. ^{[1
]}

Keegan M.T. ^{[2
]}

Seferian E.G. ^{[1
,3
]}

Hubmayr R.D. ^{[1
]}

Peters S.G. ^{[1
]}

机构：

[1] Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN

[2] Division of Critical Care, Department of Anesthesia, Mayo Clinic College of Medicine, Rochester, MN

[3] Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN

来源：

BMC Emergency Medicine | / 7卷 / 1期

关键词：

Acute Lung Injury; Intensive Insulin Therapy; Intensive Care Unit Length; Lung Protective Strategy; Medical Intensive Care Unit Stay;

D O I：

10.1186/1471-227X-7-10

中图分类号：

学科分类号：

摘要：

Background: Recently completed clinical trials have shown that certain interventions improve the outcome of the critically ill. To facilitate the implementation of these interventions, professional organizations have developed guidelines. Although the impacts of the individual evidence-based interventions have been well described, the overall impact on outcome of introducing multiple evidence-based protocols has not been well studied. The objective of this study was to determine the impact of introducing multiple evidence-based protocols on patient outcome. Methods: A retrospective, cohort study of 8,386 patients admitted to the medical intensive care unit (MICU) of an academic, tertiary medical center, from January 2000 through June 2005 was performed. Four evidence-based protocols (lung protective strategy for acute lung injury, activated protein C for severe sepsis/septic shock, intravenous insulin for hyperglycemia control and a protocol for sedation/analgesia) were introduced in the MICU between February 2002 and April 2004. We considered the time from January 2000 through January 2002 as the pre-protocol period, from February 2002 through March 2004 as the transition period and from April 2004 through June 2005 as the protocol period. We retrieved data including demographics, severity of illness as measured by the Acute Physiology and Chronic Health Evaluation (APACHE) III, MICU length of stay and hospital mortality. Student's t, Kruskal-Wallis, Mann-Whitney U, chi square and multiple logistic regression analyses were used to compare differences between groups. P-values < 0.05 were considered significant. Results: The predicted mean mortality rates were 20.7%, 21.1% and 21.8%, with the observed mortality rates of 19.3%, 18.0% and 16.9% during the pre-protocol, transition and protocol periods, respectively. Using the pre-protocol period as a reference, the severity-ad justed risk (95% confidence interval) of dying was 0.777 (0.655-0.922) during the protocol period (P = 0.0038). The average 28-day MICU free days improved during the protocol period compared to the pre-protocol period. The benefit was limited to sicker patients and those who stayed in the MICU longer. Conclusion: The introduction of multiple evidence-based protocols is associated with improved outcome in critically ill medical patients. © 2007 Afessa et al; licensee BioMed Central Ltd.

引用

共 31 条

[1]

Halpern N.A., Pastores S.M., Greenstein R.J., Critical care medicine in the United States 1985-2000: An analysis of bed numbers, use, and costs, Crit Care Med, 32, pp. 1254-1259, (2004)

[2]

Kress J.P., Pohlman A.S., O'Connor M.F., Hall J.B., Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation, N Engl J Med, 342, pp. 1471-1477, (2000)

[3]

Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M., Early goal-directed therapy in the treatment of severe sepsis and septic shock, N Engl J Med, 345, pp. 1368-1377, (2001)

[4]

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network, N Engl J Med, 342, pp. 1301-1308, (2000)

[5]

Van den B.G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R., Intensive insulin therapy in the critically ill patients, N Engl J Med, 345, pp. 1359-1367, (2001)

[6]

van den B.G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Van Wijngaerden E., Bobbaers H., Bouillon R., Intensive insulin therapy in the medical ICU, N Engl J Med, 354, pp. 449-461, (2006)

[7]

Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., Fisher Jr. C.J., Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, 344, pp. 699-709, (2001)

[8]

Kahn J.M., Rubenfeld G.D., Translating evidence into practice in the intensive care unit: The need for a systems-based approach, J Crit Care, 20, pp. 204-206, (2005)

[9]

Rubenfeld G.D., Cooper C., Carter G., Thompson B.T., Hudson L.D., Barriers to providing lung-protective ventilation to patients with acute lung injury, Crit Care Med, 32, pp. 1289-1293, (2004)

[10]

Schultz M.J., Wolthuis E.K., Moeniralam H.S., Levi M., Struggle for implementation of new strategies in intensive care medicine: Anticoagulation, insulin, and lower tidal volumes, J Crit Care, 20, pp. 199-204, (2005)

← 1 2 3 4 →